Does the DPP4 Inhibitor (Sitagliptin) Increase Endometrial Mesenchymal Stem Cells in Women with Recurrent Miscarriage?
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2019
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Acronyms SIMPLANT
- 05 Sep 2017 Last checked against ISRCTN: Current Controlled Trials.
- 02 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 New trial record